TGFB1 and chronic kidney disease: TGFβ suppresses the PPARA’s expression in chronic kidney disease (CKD) patients with kidney fibrosis (Kang et al. 2015) and our in vitro and in vivo studies showed that PPARA or PPARGC1A was down-regulated by zoledronate treatments.